Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957502 · ClinicalTrials.gov registry record · NA
ENTact™ Septal Stapler Shelf Life Extension
A NA study of Deviated Nasal Septum, sponsored by ENTrigue Surgical.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT00957502: Completed NA study of Deviated Nasal Septum, sponsored by ENTrigue Surgical.
NCT00957502 is a NA study of Deviated Nasal Septum that has completed, run by ENTrigue Surgical. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00957502, a NA study of Deviated Nasal Septum, has completed, sponsored by ENTrigue Surgical.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective, limited-use evaluation of the ENTact™ Septal Stapler for tissue approximation utilizing staples with extended shelf life. The ENTact™ Septal Stapler will be used to approximate the mucoperichondrial flaps in all patients. Each treatment group will be implanted with product that has been aged for a specified amount of time.
Conditions Studied
Interventions
- DEVICE ENTact™ Septal Stapler
Study Locations (1)
Ohio
- Good Samaritan Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT00957502 record still lists
NCT00957502 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Deviated Nasal Septum appearing as the primary indexed condition, and to 1 intervention - of which ENTact™ Septal Stapler is the first listed.
NCT00957502 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00957502 about?
NCT00957502 is a clinical study titled "ENTact™ Septal Stapler Shelf Life Extension". This study is a prospective, limited-use evaluation of the ENTact™ Septal Stapler for tissue approximation utilizing staples with extended shelf life. The ENTact™ Septal Stapler will be used to approximate the mucoperichondrial flaps in all patients. Each treatment group will be implanted with produ...
What is the current status of trial NCT00957502?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2009-07. Estimated completion is 2010-02.
What conditions does trial NCT00957502 study?
This clinical trial studies the following conditions: Deviated Nasal Septum.
What interventions are being tested in trial NCT00957502?
The interventions under investigation include: ENTact™ Septal Stapler (DEVICE).
Who is sponsoring clinical trial NCT00957502?
This trial is sponsored by ENTrigue Surgical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00957502 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deviated Nasal Septum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00957502's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia